| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
24,633 |
22,314 |
$7.04M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
20,954 |
18,933 |
$4.14M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,581 |
5,059 |
$830K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,096 |
1,903 |
$738K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,871 |
3,590 |
$486K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,617 |
4,131 |
$198K |
| 99233 |
Prolong inpt eval add15 m |
3,408 |
825 |
$142K |
| 71045 |
Radiologic examination, chest; single view |
1,456 |
1,300 |
$89K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,859 |
1,973 |
$71K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,920 |
567 |
$67K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,917 |
1,830 |
$64K |
| 88142 |
|
2,855 |
2,730 |
$63K |
| 99223 |
Prolong inpt eval add15 m |
528 |
495 |
$55K |
| G0410 |
Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes |
232 |
24 |
$52K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
956 |
850 |
$47K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,344 |
1,233 |
$42K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,343 |
1,232 |
$42K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,183 |
1,964 |
$39K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
126 |
120 |
$38K |
| 80053 |
Comprehensive metabolic panel |
36,098 |
32,059 |
$36K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
94 |
91 |
$33K |
| 36415 |
Collection of venous blood by venipuncture |
39,200 |
34,400 |
$24K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
818 |
628 |
$22K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,898 |
1,737 |
$21K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
151 |
64 |
$18K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
10,784 |
7,424 |
$15K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
712 |
613 |
$15K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
619 |
558 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
413 |
364 |
$13K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
223 |
94 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
32,579 |
28,831 |
$11K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
211 |
175 |
$10K |
| 80061 |
Lipid panel |
983 |
899 |
$10K |
| 93296 |
|
1,188 |
879 |
$9K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
342 |
277 |
$8K |
| 77336 |
|
99 |
36 |
$8K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
138 |
122 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
788 |
708 |
$5K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
35 |
33 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
183 |
171 |
$4K |
| 70450 |
Computed tomography, head or brain; without contrast material |
34 |
26 |
$4K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
137 |
103 |
$3K |
| 81514 |
|
13 |
13 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
74 |
71 |
$3K |
| 82274 |
|
165 |
157 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
115 |
98 |
$2K |
| 99222 |
Initial hospital care, per day, moderate complexity |
24 |
24 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
31 |
28 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
474 |
427 |
$2K |
| 99220 |
|
14 |
14 |
$2K |
| 72110 |
|
27 |
24 |
$2K |
| 85027 |
|
544 |
486 |
$2K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
14 |
13 |
$2K |
| 86780 |
|
147 |
139 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,616 |
6,636 |
$1K |
| 86850 |
|
68 |
65 |
$1K |
| 86803 |
|
73 |
72 |
$876.18 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
13 |
12 |
$871.55 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
61 |
54 |
$765.05 |
| A9270 |
Non-covered item or service |
3,852 |
2,863 |
$708.06 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
14 |
13 |
$698.54 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
14 |
12 |
$688.61 |
| 93294 |
|
141 |
100 |
$546.53 |
| 94726 |
|
28 |
27 |
$542.17 |
| 87081 |
|
91 |
89 |
$462.11 |
| 82728 |
|
100 |
93 |
$439.23 |
| 86140 |
|
145 |
133 |
$419.01 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
30 |
12 |
$384.14 |
| 93248 |
|
91 |
70 |
$320.78 |
| 84481 |
|
14 |
13 |
$203.28 |
| 0298T |
|
85 |
72 |
$190.07 |
| 94729 |
|
33 |
31 |
$180.51 |
| 86704 |
|
17 |
17 |
$168.70 |
| 81001 |
|
13,413 |
12,072 |
$167.55 |
| 86709 |
|
17 |
17 |
$166.99 |
| 84439 |
|
28 |
26 |
$153.34 |
| 86706 |
|
17 |
17 |
$150.36 |
| 87340 |
|
17 |
17 |
$144.62 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
426 |
351 |
$89.26 |
| 94060 |
|
13 |
12 |
$84.54 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
531 |
493 |
$76.64 |
| 73030 |
|
14 |
12 |
$74.56 |
| 82247 |
|
15 |
12 |
$58.73 |
| G0411 |
Interactive group psychotherapy, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes |
71 |
12 |
$57.45 |
| 84703 |
|
949 |
871 |
$21.00 |
| 85652 |
|
16 |
14 |
$20.10 |
| 73140 |
|
19 |
13 |
$19.17 |
| 83690 |
|
4,078 |
3,700 |
$17.89 |
| 84484 |
|
1,299 |
1,058 |
$14.08 |
| 99024 |
|
63 |
51 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
98 |
93 |
$0.00 |
| 87077 |
|
13 |
13 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
21 |
18 |
$0.00 |
| 80306 |
|
453 |
408 |
$0.00 |
| 81003 |
|
16 |
12 |
$0.00 |
| G0177 |
Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) |
242 |
24 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
25 |
12 |
$0.00 |
| 97803 |
|
72 |
62 |
$0.00 |
| 81025 |
|
55 |
50 |
$0.00 |
| 87186 |
|
13 |
13 |
$0.00 |
| 76000 |
|
19 |
14 |
$0.00 |
| 87210 |
|
12 |
12 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
14 |
12 |
$0.00 |